Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial

OBJECTIVE: To assess the efficacy and safety of a 1:1 fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) versus lixisenatide (Lixi) in insulin-naive Japanese patients with type 2 diabetes mellitus (T2DM) inadequately controlled on oral antidiabetic drugs (OADs). RESEARCH DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales: Watada, Hirotaka, Takami, Akane, Spranger, Robert, Amano, Atsushi, Hashimoto, Yasuhiro, Niemoeller, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245357/
https://www.ncbi.nlm.nih.gov/pubmed/32295808
http://dx.doi.org/10.2337/dc19-2452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245357/
https://www.ncbi.nlm.nih.gov/pubmed/32295808
http://dx.doi.org/10.2337/dc19-2452

Ejemplares similares